Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-132.44%
operating margin TTM
-95.69%
revenue TTM
6.03 Million
revenue per share TTM
4.41$
valuation ratios | |
|---|---|
| pe ratio | -0.57 |
| peg ratio | -0.02 |
| price to book ratio | 0.65 |
| price to sales ratio | 0.76 |
| enterprise value multiple | -0.91 |
| price fair value | 0.65 |
profitability ratios | |
|---|---|
| gross profit margin | 37.67% |
| operating profit margin | -95.69% |
| pretax profit margin | -108.84% |
| net profit margin | -132.44% |
| return on assets | -52.07% |
| return on equity | -72.49% |
| return on capital employed | -46.42% |
liquidity ratio | |
|---|---|
| current ratio | 3.61 |
| quick ratio | 3.25 |
| cash ratio | 1.66 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 99.63 |
| operating cycle | 310.42 |
| days of payables outstanding | 77.47 |
| cash conversion cycle | 232.95 |
| receivables turnover | 1.73 |
| payables turnover | 4.71 |
| inventory turnover | 3.66 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.02 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.02 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -62.11 |
cash flow ratios | |
|---|---|
| free cash flow per share | -7.07 |
| cash per share | 3.11 |
| operating cash flow per share | -7.06 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -62.11 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -601.69 |
Frequently Asked Questions
When was the last time Arcadia Biosciences, Inc. (NASDAQ:RKDA) reported earnings?
Arcadia Biosciences, Inc. (RKDA) published its most recent earnings results on 12-11-2024.
What is Arcadia Biosciences, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Arcadia Biosciences, Inc. (NASDAQ:RKDA)'s trailing twelve months ROE is -72.49%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Arcadia Biosciences, Inc. (RKDA) currently has a ROA of -52.07%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did RKDA's net profit margin stand at?
RKDA reported a profit margin of -132.44% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is RKDA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.61 in the most recent quarter. The quick ratio stood at 3.25, with a Debt/Eq ratio of 0.02.